Innovent Biologics (信达生物) IPO: PD-1 およびバイオシミラー競争の価格設定 (パート 2)

743 Views10 Oct 2018 11:05

中国の大手バイオ医薬品企業であるInnovent Biologicsは、香港上場に向けて最大5億米ドルを調達する予定です。前回のインサイト（リンク…）では、この件について触れました。

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 7-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream